George Georgiou

This inventor holds 76 USPTO granted patents and 19 published patent applications, plus 8 CIPO patents and 18 EPO patents, primarily in Engineered Enzymes (CPC class C07K). Top assignees: The University of Texas System, Research Development Foundation, Aemase, Inc.. Active years: 1993-2026.

USPTO Granted Patents = 76 (Patent Applications = 19)

% Patents Active = 86.8

CIPO Patents = 8 (Patent Applications = 10)

EPO Patents = 18 (Patent Applications = 30)

Average Co-Inventor Count = 2.6

ph-index = 15

Forward Citations = 1,344(Granted Patents)

Forward Citations (Not Self Cited) = 1,178(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

44 out of 5,627

The University of Texas System

patents

18 out of 299

Research Development Foundation

12. 1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2026

Loading Chart...

Areas of Expertise:

Kynureninase

Antibody Variants

Tumor Therapy

Immunoglobulin Fc

Methionine-Gamma-Lyase

Cystine Degrading Enzymes

Homocysteine Depletion

Proteomic Identification

Therapeutic Uses

High Throughput Sequencing

Kinase Inhibitor Resistance

Protein Interactions

76 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12692485 - PEGYLATED KYNURENINASE ENZYMES AND USES THEREOF FOR THE TREATMENT OF CANCER (2026-07-28),

2. 12680089 - ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY (2026-07-14),

3. 12144828 - Human Kynureninase enzymes and uses thereof (2024-11-19),

4. 12036269 - Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria (2024-07-16),

5. 11958904 - Engineered antibody Fc variants for enhanced serum half life (2024-04-16),

6. 11866785 - Tumor specific antibodies and T-cell receptors and methods of identifying the same (2024-01-09),

7. 11648272 - Human kynureninase enzymes and uses thereof (2023-05-16),

8. 11584949 - Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof (2023-02-21),

9. 11542486 - Human kynureninase enzyme variants having improved pharmacological properties (2023-01-03),

10. 11534463 - Nucleic acids encoding kynurenine depleting enzymes (2022-12-27),

11. 11426464 - Engineered primate cystine/cysteine degrading enzymes as antineogenic agents (2022-08-30),

12. 11332538 - Engineered immunoglobulin Fc polypeptides displaying improved complement activation (2022-05-17),

13. 11236380 - Methods for predicting kinase inhibitor resistance (2022-02-01),

14. 11168142 - Administration of kynurenine depleting enzymes for tumor therapy (2021-11-09),

15. 11059892 - Engineered antibody Fc variants for enhanced serum half life (2021-07-13),

Title: The Innovative Mind of George Georgiou

Introduction: George Georgiou, a talented inventor based in Austin, TX, is a pioneering woman in the field of technology and innovation. Her groundbreaking work has left a lasting impact on various industries.

Latest Patents: George Georgiou holds several patents in the field of artificial intelligence and renewable energy technologies, showcasing her commitment to creating sustainable solutions for the future.

Career Highlights: With a career spanning over two decades, George Georgiou has worked with leading tech companies to develop cutting-edge products that have revolutionized the way we interact with technology. Her innovative spirit and dedication to excellence have earned her recognition as a trailblazer in the industry.

Collaborations: Throughout her career, George Georgiou has collaborated with top researchers, engineers, and scientists to bring her ideas to life. Her ability to work effectively in multidisciplinary teams has led to the successful implementation of groundbreaking projects.

Conclusion: George Georgiou's passion for innovation and her relentless drive to push the boundaries of what is possible make her a true visionary in the world of technology. Her contributions continue to inspire future generations of inventors and innovators.